AutoresRosa María Ruiz-Calero Cendrero, Bárbara Cancho Castellano, María Victoria Martín Hidalgo-Barquero, María Cruz Cid Parra, Josefa Galán González, María Antonia Fernández Solís, Olga Sánchez García
Hepatitis B virus (HBV) is a serious world health problem.In year 2015, the estimated prevalence in the general population was 3.5%. 1 The morbidity and mortality associated with HBV-related chronic hepatitis is linked to the persistence of viral replication and progression to cirrhosis and/or hepatocellular carcinoma.One difficulty with HBV is the high risk of contamination, which magnifies the problem. 2 Patients on haemodialysis (HD) are at risk of HBV infection ; they are frequently transfused, and they are immunocompromised and subjected to invasive procedures with blood manipulation.They should therefore have serology testing and all seronegative patients need to be vaccinated. 3,4Thanks to this measure and isolation in the HD units according to
